OTC and dietary supplement labeling compliance under new FDA division.
This article was originally published in The Tan Sheet
Executive Summary
FDA LABELING AND OTC DRUG COMPLIANCE DIVISION ESTABLISHED under the Center for Drug Evaluation and Research's reorganized compliance office, Manufacturing and Product Quality Division Director Douglas Ellsworth reported Oct. 19 at the Nonprescription Drug Manufacturers Association's annual manufacturing seminar in Philadelphia. Formerly part of CDER's Division of Drug Labeling Compliance, which handled all new drug compliance-related issues, the new division has been restructured to deal primarily with OTC drug issues.